In contrast, ARRDC3, with a low expression level, silenced by deacetylation, resulting in downstream regulators, could neither activate miRNA MIR497 to regulate target genes to inhibit tumor progression nor suppress TF AR and miRNA MIR20A to avoid cell proliferation and accumulation of genomic damage and instability [46]. This evidence concerns the gene ARRDC3 and neoplasm.